Handelsavisen
prelaunch
Companies Healthcare HONG.KL
HO
HONG.KL Bursa Malaysia Healthcare Facilities & Services

Hong.Kl

$0,01
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
151,7 %
ROE
7,7 %
Net margin
142,4 %
Debt / equity
0,19
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

HONG.KL operates in the healthcare facilities and services industry, providing biotechnology-related services and equipment.

Business. HONG.KL operates in the healthcare facilities and services industry, providing biotechnology-related services and equipment.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
ActivityBiotechnology
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
7,7 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning HONG.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to HONG.KL. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    HONG.KL operates in the healthcare facilities and services industry, providing biotechnology-related services and equipment.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryHealthcare Facilities & Services
    ActivityBiotechnology
    AI synthesis
    GENERATED

    HONG.KL maintains a strong liquidity position with a current ratio of 11.82, indicating the company can easily cover its short-term liabilities with its current assets. However, the company's operating cash flow is negative at -44,926,720 MYR, which may signal potential challenges in generating sufficient cash from operations to sustain its activities. The debt-to-equity ratio of 0.19 suggests a relatively low level of leverage, with total liabilities of 72,403,220 MYR compared to total equity of 311,913,390 MYR.

    In terms of profitability, HONG.KL reports a return on equity (ROE) of 7.68% and a return on assets (ROA) of 6.24%, which are positive indicators of the company's ability to generate returns for shareholders and utilize its assets efficiently. Despite a gross loss of -27,861,110 MYR, the company managed to achieve an operating income of 25,518,380 MYR and a net income of 23,962,550 MYR, demonstrating resilience in its core operations.

    The company's revenue is concentrated in a single segment, as disclosed in its financial statements, with no additional geographic or segment breakdown provided in the available data. This lack of diversification may expose the company to higher risk if demand in its primary market fluctuates.

    Looking ahead, HONG.KL's revenue outlook is uncertain, as the company's last actual revenue was reported at 54,109,000 MYR, significantly lower than its total revenue of 16,821,860 MYR. This discrepancy may indicate a need for further investigation into the company's reporting practices or potential data inconsistencies.

    The company faces a medium liquidity risk due to its negative net cash position after subtracting total debt, which could impact its ability to meet short-term obligations without external financing. Additionally, the risk assessment indicates a low potential for dilution, suggesting that the company is not currently issuing new shares at a rate that would significantly affect existing shareholders.

    Recent events, including the latest financial filing, show a mixed performance with a net income but also a negative operating cash flow, which may raise concerns about the company's long-term sustainability and cash management practices.

    Key takeaways
    • HONG.KL has a strong current ratio of 11.82, indicating robust short-term liquidity.
    • The company's ROE of 7.68% and ROA of 6.24% suggest efficient use of equity and assets.
    • Despite a gross loss, HONG.KL achieved positive operating and net income, showing operational resilience.
    • The company's negative operating cash flow and net cash position after debt raise liquidity concerns.
    • Revenue concentration in a single segment may increase business risk.
    • The discrepancy between reported revenue and analyst estimates warrants further scrutiny.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $0,01
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $311.9M
    Net cash
    -$60.4M
    Current ratio
    11.8
    Debt / equity
    0.2
    ROA
    6.2%
    ROE
    7.7%
    Cash conversion
    -187.0%
    CapEx / revenue
    -82.3%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin151,7 %Best in class
    Net Margin142,5 %Best in class
    ROE7,7 %Above median
    Capex / Rev-82,3 %Bottom quartile
    D/E0,19Above median
    Cash Conv-1,87Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • HONG.KL Market data — financials · 2026-05-28
    • Hong Seng Consolidated Bhd Market data — analyst estimates · 2026-05-28

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    1.5Kshares short+308.1% vs prior
    1days to cover
    72.3%short of daily vol
    168fails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    HONG.KLCanonical
    Bursa Malaysia · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage